Latest News for: klk1

Edit

Waltham’s KACTUS Introduces Ultra-Low Endotoxin KLK1 Proteins

GetNews 05 Mar 2026
KACTUS, a biotechnology company located in Waltham, Massachusetts, has made commercially available ultra-low endotoxin recombinant human kallikrein-1 (KLK1) proteins ... of KLK1 in cardiovascular disease.
  • 1
×